scholarly article | Q13442814 |
P50 | author | Thaíz F Borin | Q45892483 |
P2093 | author name string | A S M Iskander | |
Adarsh Shankar | |||
Ali Syed Arbab | |||
Nadimpalli Ravi S Varma | |||
Juliana Garcia de Oliveira | |||
Bruna Victorasso Jardim-Perassi | |||
Gabriela Bottaro Gelaleti | |||
Lívia Carvalho Ferreira | |||
Marina Gobbe Moschetta | |||
Debora Aparecida Pires de Campos Zuccari | |||
Vanessa Alves Fabri | |||
Verena Benedick Coimbra | |||
P2860 | cites work | ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration | Q39982031 |
CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells | Q40038415 | ||
Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model | Q40059262 | ||
Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice | Q40125447 | ||
Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C. | Q40173626 | ||
Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway | Q40600338 | ||
Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure | Q40656261 | ||
Melatonin induced cyclic modulation of vectorial water transport in kidney-derived MDCK cells | Q40664763 | ||
PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells | Q40860460 | ||
Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? | Q44032689 | ||
The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice | Q44242219 | ||
Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT. | Q44539364 | ||
Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro | Q44558507 | ||
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin | Q48165379 | ||
The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and i | Q48393043 | ||
Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines. | Q51632261 | ||
The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system | Q68223387 | ||
Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin | Q71083616 | ||
Application of Tc-99m-tetrofosmin as a tumor imaging agent: comparison with Tl-201 | Q71518885 | ||
Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene | Q73494216 | ||
Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells | Q77391862 | ||
Global cancer statistics | Q22241238 | ||
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors | Q24623433 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
In vivo X-ray computed tomographic imaging of soft tissue with native, intravenous, or oral contrast | Q26824103 | ||
Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells | Q28207731 | ||
A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells | Q28379602 | ||
Rho GTPases and cell migration | Q29616714 | ||
Alterations in F-actin distribution in cells treated with melatonin | Q32125016 | ||
Melatonin, experimental basis for a possible application in breast cancer prevention and treatment | Q33917632 | ||
Regulation of ROCK1 via Notch1 during breast cancer cell migration into dense matrices. | Q34268182 | ||
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway | Q34613650 | ||
ROCK inhibition activates MCF-7 cells | Q35093634 | ||
Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance | Q35142784 | ||
Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells | Q36904849 | ||
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. | Q36922699 | ||
Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression | Q37265640 | ||
Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer | Q37458674 | ||
Melatonin signaling and cell protection function | Q37763812 | ||
Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis | Q37799571 | ||
Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation | Q38002452 | ||
Molecular mechanisms of melatonin's inhibitory actions on breast cancers. | Q38046127 | ||
Extrapineal melatonin: sources, regulation, and potential functions. | Q38189699 | ||
Lung tumour markers in oncology practice: a study of TPA and CA125 | Q38290763 | ||
Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma | Q39208543 | ||
Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro | Q39574224 | ||
Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. | Q39593800 | ||
Molecular mechanisms of melatonin anticancer effects | Q39755885 | ||
Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone | Q39779365 | ||
Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion | Q39929040 | ||
P433 | issue | 1 | |
P921 | main subject | breast cancer | Q128581 |
melatonin | Q180912 | ||
cancer metastasis | Q120912394 | ||
P304 | page(s) | 3-15 | |
P577 | publication date | 2015-10-20 | |
P1433 | published in | Journal of Pineal Research | Q15056565 |
P1476 | title | Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression | |
P478 | volume | 60 |
Q42366169 | "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma |
Q89658833 | A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics |
Q38935714 | Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. |
Q59808521 | Artificial Light at Night of Different Spectral Compositions Differentially Affects Tumor Growth in Mice: Interaction With Melatonin and Epigenetic Pathways |
Q33616780 | Dietary Sources and Bioactivities of Melatonin |
Q92324031 | Ebola Hemorrhagic Shock Syndrome-on-a-Chip |
Q35943145 | Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines |
Q64935328 | Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion. |
Q88802576 | Evaluation of melatonin and AFMK levels in women with breast cancer |
Q33793046 | HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model |
Q47578133 | Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma |
Q46454235 | Long-term melatonin treatment delays ovarian aging |
Q90639866 | Mechanisms Underlying Tumor Suppressive Properties of Melatonin |
Q58753365 | Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction |
Q92749740 | Melatonin Regulates Breast Cancer Progression by the lnc010561/miR-30/FKBP3 Axis |
Q58753461 | Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair |
Q41660894 | Melatonin and Hippo Pathway: Is There Existing Cross-Talk? |
Q46259060 | Melatonin and Metformin Diminish Oxidative Stress in Heart Tissue in a Rat Model of High Fat Diet and Mammary Carcinogenesis. |
Q39346336 | Melatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms |
Q26751220 | Melatonin as a potential anticarcinogen for non-small-cell lung cancer |
Q47112398 | Melatonin as a potential inhibitory agent in head and neck cancer |
Q37164560 | Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells |
Q33889427 | Melatonin for the prevention and treatment of cancer |
Q58794834 | Melatonin for the treatment of spinal cord injury |
Q49323107 | Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils |
Q55339336 | Melatonin rescued interleukin 1β-impaired chondrogenesis of human mesenchymal stem cells. |
Q45394478 | Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation. |
Q33624824 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis |
Q41145166 | Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness |
Q41651606 | Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy |
Q58587207 | Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers |
Q47569519 | Melatonin: does it have utility in the treatment of haematological neoplasms? |
Q97069593 | MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis |
Q97419539 | Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells |
Q28073105 | Phenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative Stress |
Q58554204 | Promising Antineoplastic Actions of Melatonin |
Q61806619 | RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model |
Q41036251 | The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy |
Q47103306 | The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells |
Q89505525 | The role of melatonin on miRNAs modulation in triple-negative breast cancer cells |
Q47134459 | Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology. |